RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $622,000 | +59.1% | 177,810 | -16.9% | 0.49% | +156.8% |
| Q2 2020 | $391,000 | -24.8% | 214,040 | -35.8% | 0.19% | -40.0% |
| Q1 2020 | $520,000 | +1825.9% | 333,389 | +2532.6% | 0.32% | +2361.5% |
| Q4 2019 | $27,000 | -94.2% | 12,664 | -94.9% | 0.01% | -95.1% |
| Q3 2019 | $469,000 | -21.2% | 250,693 | +10.0% | 0.27% | -18.8% |
| Q2 2019 | $595,000 | +28.5% | 227,943 | +4.0% | 0.33% | +27.5% |
| Q1 2019 | $463,000 | +131.5% | 219,143 | +150.7% | 0.26% | +70.9% |
| Q4 2018 | $200,000 | +525.0% | 87,400 | +774.0% | 0.15% | +529.2% |
| Q3 2018 | $32,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |